David Young Chung, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cortical Spreading Depression | 18 | 2022 | 275 | 4.610 |
Why?
|
| Subarachnoid Hemorrhage | 14 | 2022 | 1059 | 4.030 |
Why?
|
| Hydrocephalus | 4 | 2021 | 731 | 1.510 |
Why?
|
| Head Injuries, Closed | 2 | 2022 | 141 | 1.010 |
Why?
|
| Vasospasm, Intracranial | 3 | 2021 | 209 | 0.830 |
Why?
|
| Brain Ischemia | 6 | 2022 | 3292 | 0.780 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 2 | 2020 | 46 | 0.760 |
Why?
|
| Ventriculostomy | 2 | 2018 | 132 | 0.750 |
Why?
|
| Cerebrospinal Fluid Shunts | 2 | 2019 | 196 | 0.750 |
Why?
|
| Brain Stem Hemorrhage, Traumatic | 1 | 2017 | 14 | 0.650 |
Why?
|
| Cerebrovascular Circulation | 6 | 2022 | 2751 | 0.650 |
Why?
|
| Pupil Disorders | 1 | 2017 | 27 | 0.650 |
Why?
|
| Drainage | 2 | 2021 | 1136 | 0.640 |
Why?
|
| Cerebral Cortex | 5 | 2022 | 5718 | 0.590 |
Why?
|
| Intracranial Hypertension | 1 | 2018 | 182 | 0.570 |
Why?
|
| Intracranial Aneurysm | 5 | 2021 | 1303 | 0.490 |
Why?
|
| Brain Concussion | 2 | 2022 | 1305 | 0.480 |
Why?
|
| Oximetry | 1 | 2016 | 466 | 0.460 |
Why?
|
| Visual Cortex | 1 | 2020 | 1138 | 0.450 |
Why?
|
| Cerebral Angiography | 2 | 2021 | 1382 | 0.400 |
Why?
|
| Migraine with Aura | 3 | 2020 | 199 | 0.370 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2009 | 99 | 0.360 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2009 | 133 | 0.340 |
Why?
|
| Disease Management | 1 | 2019 | 2534 | 0.340 |
Why?
|
| Disease Models, Animal | 11 | 2022 | 18345 | 0.330 |
Why?
|
| Brain Injuries | 1 | 2019 | 1915 | 0.330 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 3701 | 0.320 |
Why?
|
| Disulfides | 1 | 2009 | 462 | 0.310 |
Why?
|
| Intensive Care Units | 2 | 2020 | 3441 | 0.270 |
Why?
|
| Cysteine | 1 | 2009 | 871 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 10 | 2022 | 22941 | 0.250 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2021 | 34394 | 0.240 |
Why?
|
| Animals | 26 | 2022 | 170733 | 0.230 |
Why?
|
| Behavior, Animal | 2 | 2020 | 1915 | 0.220 |
Why?
|
| Endovascular Procedures | 3 | 2021 | 1960 | 0.220 |
Why?
|
| Weaning | 1 | 2021 | 110 | 0.210 |
Why?
|
| CADASIL | 1 | 2022 | 80 | 0.210 |
Why?
|
| Head Injuries, Penetrating | 1 | 2021 | 30 | 0.210 |
Why?
|
| Embolization, Therapeutic | 2 | 2021 | 1383 | 0.210 |
Why?
|
| Rotarod Performance Test | 1 | 2020 | 64 | 0.210 |
Why?
|
| Mice | 17 | 2022 | 80997 | 0.200 |
Why?
|
| Leukoaraiosis | 1 | 2022 | 138 | 0.200 |
Why?
|
| Neurons | 2 | 2019 | 9419 | 0.190 |
Why?
|
| Phenytoin | 1 | 2020 | 193 | 0.190 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2021 | 201 | 0.190 |
Why?
|
| Migraine Disorders | 3 | 2020 | 1563 | 0.180 |
Why?
|
| Transcytosis | 1 | 2018 | 44 | 0.170 |
Why?
|
| Maze Learning | 1 | 2020 | 497 | 0.170 |
Why?
|
| Cerebral Infarction | 2 | 2022 | 1041 | 0.170 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2018 | 254 | 0.170 |
Why?
|
| Anticonvulsants | 2 | 2020 | 1854 | 0.170 |
Why?
|
| Mice, Transgenic | 6 | 2020 | 9925 | 0.170 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2020 | 183 | 0.160 |
Why?
|
| Caveolin 1 | 1 | 2018 | 257 | 0.150 |
Why?
|
| Brain | 4 | 2022 | 25188 | 0.150 |
Why?
|
| Pupil | 1 | 2017 | 144 | 0.150 |
Why?
|
| Hyperalgesia | 1 | 2020 | 498 | 0.150 |
Why?
|
| Pericytes | 1 | 2018 | 259 | 0.150 |
Why?
|
| Length of Stay | 2 | 2021 | 6278 | 0.140 |
Why?
|
| Piracetam | 1 | 2016 | 86 | 0.140 |
Why?
|
| Endothelium | 1 | 2018 | 804 | 0.140 |
Why?
|
| Aneurysm, Ruptured | 1 | 2020 | 479 | 0.140 |
Why?
|
| Somatosensory Cortex | 1 | 2019 | 537 | 0.130 |
Why?
|
| Intracranial Thrombosis | 1 | 2015 | 124 | 0.130 |
Why?
|
| Anesthetics | 1 | 2019 | 523 | 0.120 |
Why?
|
| Humans | 24 | 2022 | 715118 | 0.120 |
Why?
|
| Male | 21 | 2022 | 351080 | 0.120 |
Why?
|
| Wakefulness | 1 | 2019 | 1178 | 0.110 |
Why?
|
| Seizures | 2 | 2022 | 2583 | 0.110 |
Why?
|
| Light | 1 | 2018 | 1444 | 0.110 |
Why?
|
| Motor Cortex | 1 | 2019 | 962 | 0.110 |
Why?
|
| Depression | 2 | 2021 | 7256 | 0.100 |
Why?
|
| Cerebral Arteries | 1 | 2012 | 501 | 0.100 |
Why?
|
| Treatment Outcome | 5 | 2021 | 62186 | 0.090 |
Why?
|
| Blood Transfusion | 1 | 2016 | 1258 | 0.090 |
Why?
|
| Dithiothreitol | 1 | 2009 | 106 | 0.090 |
Why?
|
| Cerebral Hemorrhage | 1 | 2020 | 2561 | 0.090 |
Why?
|
| Gene Knock-In Techniques | 2 | 2021 | 448 | 0.090 |
Why?
|
| Prospective Studies | 3 | 2021 | 51182 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 4639 | 0.080 |
Why?
|
| Oxygen | 1 | 2019 | 4169 | 0.080 |
Why?
|
| Corpus Callosum | 2 | 2022 | 731 | 0.080 |
Why?
|
| Retrospective Studies | 5 | 2021 | 72253 | 0.080 |
Why?
|
| Blood Pressure | 3 | 2020 | 8566 | 0.080 |
Why?
|
| Cricetulus | 1 | 2009 | 856 | 0.080 |
Why?
|
| Anxiety | 1 | 2020 | 3898 | 0.070 |
Why?
|
| CHO Cells | 1 | 2009 | 1442 | 0.070 |
Why?
|
| Protein Structure, Secondary | 1 | 2009 | 1226 | 0.070 |
Why?
|
| Cognition | 1 | 2022 | 6081 | 0.070 |
Why?
|
| Cricetinae | 1 | 2009 | 2595 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2019 | 4168 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2020 | 8602 | 0.060 |
Why?
|
| Female | 11 | 2021 | 377328 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2020 | 21789 | 0.060 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3158 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3276 | 0.050 |
Why?
|
| Bicuculline | 1 | 2021 | 100 | 0.050 |
Why?
|
| Milrinone | 1 | 2021 | 85 | 0.050 |
Why?
|
| Desoxycorticosterone | 1 | 2020 | 51 | 0.050 |
Why?
|
| 4-Aminopyridine | 1 | 2021 | 85 | 0.050 |
Why?
|
| Kainic Acid | 1 | 2021 | 205 | 0.050 |
Why?
|
| Potassium Channel Blockers | 1 | 2021 | 175 | 0.050 |
Why?
|
| rho-Associated Kinases | 1 | 2022 | 282 | 0.050 |
Why?
|
| Pancreatic Elastase | 1 | 2020 | 152 | 0.050 |
Why?
|
| Tetrodotoxin | 1 | 2021 | 257 | 0.050 |
Why?
|
| Hypoalbuminemia | 1 | 2020 | 62 | 0.050 |
Why?
|
| Mice, Inbred ICR | 1 | 2020 | 378 | 0.050 |
Why?
|
| Inflammation | 1 | 2019 | 10085 | 0.050 |
Why?
|
| Rats | 3 | 2020 | 25090 | 0.050 |
Why?
|
| Scalp | 1 | 2022 | 377 | 0.040 |
Why?
|
| Endothelin-1 | 1 | 2020 | 314 | 0.040 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2022 | 474 | 0.040 |
Why?
|
| Vibrissae | 1 | 2019 | 131 | 0.040 |
Why?
|
| Penicillins | 1 | 2021 | 359 | 0.040 |
Why?
|
| Hyperemia | 1 | 2019 | 226 | 0.040 |
Why?
|
| Potassium | 1 | 2022 | 1329 | 0.040 |
Why?
|
| Vagus Nerve | 1 | 2020 | 447 | 0.040 |
Why?
|
| Valproic Acid | 1 | 2020 | 447 | 0.040 |
Why?
|
| Nervous System | 1 | 2021 | 563 | 0.040 |
Why?
|
| Physical Stimulation | 1 | 2019 | 543 | 0.040 |
Why?
|
| Receptors, Notch | 1 | 2022 | 761 | 0.040 |
Why?
|
| Adult | 3 | 2021 | 212128 | 0.040 |
Why?
|
| Injections | 1 | 2020 | 875 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2021 | 1529 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 20397 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 14237 | 0.040 |
Why?
|
| Tight Junctions | 1 | 2018 | 331 | 0.040 |
Why?
|
| Brain Stem | 1 | 2021 | 847 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 18734 | 0.030 |
Why?
|
| Dogs | 1 | 2020 | 4047 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2020 | 935 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2019 | 1778 | 0.030 |
Why?
|
| Polymers | 1 | 2021 | 1629 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 2019 | 1039 | 0.030 |
Why?
|
| Rabbits | 1 | 2020 | 5149 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2021 | 1757 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2018 | 1003 | 0.030 |
Why?
|
| HIV Infections | 2 | 2020 | 15616 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2022 | 2950 | 0.030 |
Why?
|
| Paraffin Embedding | 1 | 2012 | 319 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 1488 | 0.030 |
Why?
|
| Pandemics | 2 | 2021 | 7212 | 0.030 |
Why?
|
| Homeostasis | 1 | 2022 | 3340 | 0.030 |
Why?
|
| Middle Aged | 4 | 2020 | 214868 | 0.020 |
Why?
|
| Vasodilation | 1 | 2012 | 966 | 0.020 |
Why?
|
| Action Potentials | 1 | 2016 | 1792 | 0.020 |
Why?
|
| Critical Illness | 1 | 2020 | 2531 | 0.020 |
Why?
|
| Critical Care | 1 | 2020 | 2493 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 4208 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2022 | 5829 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10651 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 2015 | 2182 | 0.020 |
Why?
|
| Survival Rate | 1 | 2020 | 13255 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2015 | 2139 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 9561 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2019 | 6548 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 58503 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 23281 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8043 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29167 | 0.010 |
Why?
|
| Mutation | 1 | 2022 | 29441 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 56155 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 70705 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 162672 | 0.010 |
Why?
|